234 related articles for article (PubMed ID: 29533835)
21. Cost-effectiveness of newer technologies for the diagnosis of Mycobacterium tuberculosis infection in Brazilian people living with HIV.
Steffen RE; Pinto M; Kritski A; Trajman A
Sci Rep; 2020 Dec; 10(1):21823. PubMed ID: 33311520
[TBL] [Abstract][Full Text] [Related]
22. Risk factors associated with Tuberculosis (TB) among people living with HIV/AIDS: A pair-matched case-control study in Guangxi, China.
Cui Z; Lin M; Nie S; Lan R
PLoS One; 2017; 12(3):e0173976. PubMed ID: 28358846
[TBL] [Abstract][Full Text] [Related]
23. The economic burden to families of HIV and HIV/tuberculosis coinfection in a subsidized HIV treatment program.
Sadoh WE; Oviawe O
J Natl Med Assoc; 2007 Jun; 99(6):627-31. PubMed ID: 17595931
[TBL] [Abstract][Full Text] [Related]
24. Free tuberculosis diagnosis and treatment are not enough: patient cost evidence from three continents.
Mauch V; Bonsu F; Gyapong M; Awini E; Suarez P; Marcelino B; Melgen RE; Lönnroth K; Nhung NV; Hoa NB; Klinkenberg E
Int J Tuberc Lung Dis; 2013 Mar; 17(3):381-7. PubMed ID: 23407227
[TBL] [Abstract][Full Text] [Related]
25. The societal cost of tuberculosis: Tarrant County, Texas, 2002.
Miller TL; McNabb SJ; Hilsenrath P; Pasipanodya J; Drewyer G; Weis SE
Ann Epidemiol; 2010 Jan; 20(1):1-7. PubMed ID: 20006270
[TBL] [Abstract][Full Text] [Related]
26. The cost to health services of human immunodeficiency virus (HIV) co-infection among tuberculosis patients in Sudan.
El-Sony AI
Health Policy; 2006 Feb; 75(3):272-9. PubMed ID: 16325960
[TBL] [Abstract][Full Text] [Related]
27. Active tuberculosis and Mycobacterium tuberculosis latent infection in patients with HIV/AIDS.
Gutierrez EB; Gomes V; Picone CM; Suga H; Atomiya AN
HIV Med; 2009 Oct; 10(9):564-72. PubMed ID: 19785665
[TBL] [Abstract][Full Text] [Related]
28. Incidence and risk factors for tuberculosis in people living with HIV: cohort from HIV referral health centers in Recife, Brazil.
Batista Jd; de Albuquerque Mde F; Maruza M; Ximenes RA; Santos ML; Montarroyos UR; de Barros Miranda-Filho D; Lacerda HR; Rodrigues LC
PLoS One; 2013; 8(5):e63916. PubMed ID: 23675515
[TBL] [Abstract][Full Text] [Related]
29. Direct and indirect patient costs of tuberculosis care in India.
Chandra A; Kumar R; Kant S; Parthasarathy R; Krishnan A
Trop Med Int Health; 2020 Jul; 25(7):803-812. PubMed ID: 32306481
[TBL] [Abstract][Full Text] [Related]
30. Potent immune responses of Ag-specific Vgamma2Vdelta2+ T cells and CD8+ T cells associated with latent stage of Mycobacterium tuberculosis coinfection in HIV-1-infected humans.
Shao L; Zhang W; Zhang S; Chen CY; Jiang W; Xu Y; Meng C; Weng X; Chen ZW
AIDS; 2008 Nov; 22(17):2241-50. PubMed ID: 18981763
[TBL] [Abstract][Full Text] [Related]
31. The economic burden of tuberculosis in Denmark 1998-2010. Cost analysis in patients and their spouses.
Fløe A; Hilberg O; Wejse C; Løkke A; Ibsen R; Kjellberg J; Jennum P
Int J Infect Dis; 2015 Mar; 32():183-90. PubMed ID: 25809778
[TBL] [Abstract][Full Text] [Related]
32. The role of active case finding in reducing patient incurred catastrophic costs for tuberculosis in Nepal.
Gurung SC; Dixit K; Rai B; Caws M; Paudel PR; Dhital R; Acharya S; Budhathoki G; Malla D; Levy JW; van Rest J; Lönnroth K; Viney K; Ramsay A; Wingfield T; Basnyat B; Thapa A; Squire B; Wang D; Mishra G; Shah K; Shrestha A; de Siqueira-Filha NT
Infect Dis Poverty; 2019 Dec; 8(1):99. PubMed ID: 31791412
[TBL] [Abstract][Full Text] [Related]
33. Costs of hospitalization with respiratory syncytial virus illness among children aged <5 years and the financial impact on households in Bangladesh, 2010.
Bhuiyan MU; Luby SP; Alamgir NI; Homaira N; Sturm-Ramirez K; Gurley ES; Abedin J; Zaman RU; Alamgir A; Rahman M; Ortega-Sanchez IR; Azziz-Baumgartner E
J Glob Health; 2017 Jun; 7(1):010412. PubMed ID: 28702175
[TBL] [Abstract][Full Text] [Related]
34. Analysis of the economic burden of diagnosis and treatment on patients with tuberculosis in Bao'an district of Shenzhen City, China.
Huang Y; Huang J; Su X; Chen L; Guo J; Chen W; Zhang L
PLoS One; 2020; 15(8):e0237865. PubMed ID: 32866187
[TBL] [Abstract][Full Text] [Related]
35. Cost for tuberculosis care in developed countries: which data for an economic evaluation?
Trieste L; Turchetti G
J Rheumatol Suppl; 2014 May; 91():83-5. PubMed ID: 24789005
[TBL] [Abstract][Full Text] [Related]
36. Patient costs of accessing collaborative tuberculosis and human immunodeficiency virus interventions in Ethiopia.
Vassall A; Seme A; Compernolle P; Meheus F
Int J Tuberc Lung Dis; 2010 May; 14(5):604-10. PubMed ID: 20392354
[TBL] [Abstract][Full Text] [Related]
37. IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy.
Wergeland I; Pullar N; Assmus J; Ueland T; Tonby K; Feruglio S; Kvale D; Damås JK; Aukrust P; Mollnes TE; Dyrhol-Riise AM
J Infect; 2015 Apr; 70(4):381-91. PubMed ID: 25597826
[TBL] [Abstract][Full Text] [Related]
38. Catastrophic costs among tuberculosis-affected households in Zimbabwe: A national health facility-based survey.
Timire C; Ngwenya M; Chirenda J; Metcalfe JZ; Kranzer K; Pedrazzoli D; Takarinda KC; Nguhiu P; Madzingaidzo G; Ndlovu K; Mapuranga T; Cornell M; Sandy C
Trop Med Int Health; 2021 Oct; 26(10):1248-1255. PubMed ID: 34192392
[TBL] [Abstract][Full Text] [Related]
39. Financial burden of HIV and TB among patients in Ethiopia: a cross-sectional survey.
Assebe LF; Negussie EK; Jbaily A; Tolla MTT; Johansson KA
BMJ Open; 2020 Jun; 10(6):e036892. PubMed ID: 32487582
[TBL] [Abstract][Full Text] [Related]
40. Patient costs for the diagnosis of tuberculosis in Brazil: comparison of Xpert MTB/RIF and smear microscopy.
da Silva Antunes R; Pinto M; Trajman A
Int J Tuberc Lung Dis; 2014 May; 18(5):547-51. PubMed ID: 24903791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
